Nowadays, the study of stem cells derived from different tissues is one of the interesting topics in cell therapy and medical research. This has made the researchers to improve isolation, culture, characterization and differentiation of stem cells to regenerate damaged tissues. Although bone marrow-derived mesenchymal stem cells (BM-MSCs) have been frequently used in stem cell research but adipose tissue is an easy-to-use and less invasive source of MSCs which can be harvested by surgical procedures such as liposuction. It has been shown the amount of stem cells derived from adipose tissue is more than that of bone marrow in the same volume (
14-
16). Therefore, ADSCs may have more advantages than BM-MSCs.
It has been demonstrated MSCs lose their stemness properties during colonization
in vitro such as the ability to form colonies, differentiation capacity, and proliferation (
17). Therefore, maintenance of stem cell properties for the propagation of these cells is essential
in vitro. Stemness properties are maintained by various factors such as growth factors, cell-cell interactions, and extracellular matrix interactions (
18,
19). In this study, we have shown ciprofloxacin could improve the stemness properties of ADSCs.
Ciprofloxacin belongs to the fluoroquinolones antibiotics which inhibit bacterial DNA replication and repair by controlling DNA gyrase enzymes (
20). Ciprofloxacin is used to treat infections caused by gram-negative bacteria including Salmonella, Shigella, Campylobacter, Nyseries and Pseudomonas. On the other hand, this drug has moderate effects on gram-positive bacteria including Streptococcus pneumonia and Streptococcus faecalis. The ciprofloxacin is mainly indicated in the treatment of respiratory infections (other than Streptococcus pneumonia infection), urinary tract infections, gastrointestinal infections, including typhoid fever, bursitis, and septicemia, which are susceptible to microorganisms (
21,
22). Furthermore, Ciprofloxacin is used as a prophylactic antibiotic to prevent bacterial infections in patients undergoing stem cell transplantation. In addition, this antibiotic is widely used in cell culture
in vitro to prevent bacterial contamination including mycoplasma (
23).
Kiratipaiboon and colleagues reported that the use of ciprofloxacin improved the stemness of human dermal papilla stem cell through Akt activation and ATP-dependent tyrosine kinase/glycogen synthase kinase3β dependent mechanism (
11). They showed that colony formation and stemness of dermal papilla cells decrease gradually in a time-dependent manner during the cell culture process. Nonetheless, treatment of cells with nontoxic ciprofloxacin can maintain the morphology, colonization, and stem cell markers. Ciprofloxacin exerts its effect through Akt/GSK3β-dependent β-catenin pathway. Ciprofloxacin inhibits glycogen synthase kinase3β (GSK3β) function through Akt activation which leads to inhibition of β-catenin proteasomal degradation (
11,
24). Self-renewal capacity of stem cell is increased through upregulation of, Oct-4 and Nanog (
25). Akt activation leads to Oct4 phosphorylation which is associated with self-renewal of stem cells (
26,
27). Moreover, β-catenin upregulation triggers Nanog expression through Oct-4 which boosts MSC self-renewal (
28). Increased β-catenin activation could induce expression of epithelial-mesenchymal transition factors such as ZEB1 and Snail (
29). The major limitations of this study were that we did not investigate the exact molecular signaling pathway underlying ciprofloxacin effect on ADSCs; however, the result of this research has shown ciprofloxacin could increase Oct-4 and Nanog as important self-renewal transcription factors.